Immunetech
Executive Summary
Cam Garner to president and CEO of the San Diego-based R&D firm. Former topside Gordon Ramseier will assume the newly created position of vice chairman. Garner remains president of Dura Pharmaceuticals, an allergy products firm which was acquired by Immunetech in December ("The Pink Sheet" Feb. 5, T&G-13).
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.